However, several later studies found only a weak association between anti-β2GPI and thrombosis [69,70], and this is the main reason why the aCL or β2GPI-dependent aCL test has been dropped as a criterion of APS [36,70]. The gene discussed is APOH; the disease is autoimmune polyendocrinopathy.